|
|
Letter from the CEO Since I established DNA BioMed in 2004, one goal remains foremost in my mind - to be able to introduce our clients to the most significant, efficient and affordable products available that will allow them to maximize their laboratories' potential. Laboratories today are faced with the difficult challenge of handling increased volume while reducing costs to meet the demands of a money-conscious market. In order for clinical laboratories to remain competitive, they must find a way to increase their productivity while operating within a tight budget. The solution - laboratory automation! Automation allows laboratories to streamline their workflow and reduce bottlenecks in the pre- and post-analytical phases. It also produces faster, more reliable results in the analytical phase. With the assistance of automation, laboratories can dramatically reduce the costs of errors and labor while increasing throughput and decreasing turnaround time. Automated solutions allow laboratories to provide patients with faster, more reliable results, improve physician satisfaction and increase their capacity while maintaining a cost-effective environment. As a result, they remain competitive in today’s marketplace. With our client needs in mind, the management and sales teams at DNA BioMed seek worldwide relationships that will bring quality, cutting-edge automated technology to laboratory markets. DNA BioMed is committed to providing our customers with cost-effective solutions that will solve the unique problems that each laboratory faces. In order to reach this goal, our current product line can be customized to meet the individual needs of each laboratory. This focus and dedication to the specialized needs of each customer has resulted in significant interest and demand for our products and services nationwide. I am excited about working with you to find a customized solution to your laboratory's needs that will work to improve your efficiency, increase your throughput and reduce your costs. Sincerely, Yen Shu CEO, DNA BioMed |
copyright 2007 by DNA BioMed |